188 related articles for article (PubMed ID: 10372838)
1. Medical management of secondary hyperparathyroidism in uremia.
Drüeke TB
Am J Med Sci; 1999 Jun; 317(6):383-9. PubMed ID: 10372838
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. Effects of new vitamin D analogues on parathyroid function in chronically uraemic rats with secondary hyperparathyroidism.
Hruby M; Ureña P; Mannstadt M; Schmitt F; Lacour B; Drüeke TB
Nephrol Dial Transplant; 1996 Sep; 11(9):1781-6. PubMed ID: 8918622
[TBL] [Abstract][Full Text] [Related]
4. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
5. [Parathormone as a uremic toxin. Physiopathological bases and general therapeutic guidelines].
Brancaccio D; Galmozzi C; Pizzocaro G
Minerva Med; 1985 Mar; 76(9-10):377-82. PubMed ID: 3982693
[No Abstract] [Full Text] [Related]
6. Management of disturbed calcium metabolism in uraemic patients: 1. Use of vitamin D metabolites.
Schömig M; Ritz E
Nephrol Dial Transplant; 2000; 15 Suppl 5():18-24. PubMed ID: 11073270
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of daily and intermittent-dose calcitriol on serum parathyroid hormone and ionized calcium concentrations in normal cats and cats with chronic renal failure.
Hostutler RA; DiBartola SP; Chew DJ; Nagode LA; Schenck PA; Rajala-Schultz PJ; Drost WT
J Vet Intern Med; 2006; 20(6):1307-13. PubMed ID: 17186842
[TBL] [Abstract][Full Text] [Related]
8. New therapies for uremic secondary hyperparathyroidism.
Torres PU; Prié D; Beck L; Friedlander G
J Ren Nutr; 2006 Apr; 16(2):87-99. PubMed ID: 16567265
[TBL] [Abstract][Full Text] [Related]
9. Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.
Janssen MJ; van der Kuy A; ter Wee PM; van Boven WP
Clin Nephrol; 1996 Feb; 45(2):111-9. PubMed ID: 8846523
[TBL] [Abstract][Full Text] [Related]
10. Parathyroid growth and suppression in renal failure.
Lewin E; Huan J; Olgaard K
Semin Dial; 2006; 19(3):238-45. PubMed ID: 16689976
[TBL] [Abstract][Full Text] [Related]
11. Advances in pharmacotherapy for secondary hyperparathyroidism.
Rodríguez M; Rodríguez-Ortiz ME
Expert Opin Pharmacother; 2015; 16(11):1703-16. PubMed ID: 26159447
[TBL] [Abstract][Full Text] [Related]
12. Calcitriol in the management of secondary hyperparathyroidism of renal failure.
Daisley-Kydd RE; Mason NA
Pharmacotherapy; 1996; 16(4):619-30. PubMed ID: 8840368
[TBL] [Abstract][Full Text] [Related]
13. Successful control of hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis using magnesium carbonate and calcium carbonate as phosphate binders.
Parsons V; Baldwin D; Moniz C; Marsden J; Ball E; Rifkin I
Nephron; 1993; 63(4):379-83. PubMed ID: 8459870
[TBL] [Abstract][Full Text] [Related]
14. Drug insight: vitamin D analogs in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease.
Brown AJ; Slatopolsky E
Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):134-44. PubMed ID: 17237840
[TBL] [Abstract][Full Text] [Related]
15. Novel, selective vitamin D analog suppresses parathyroid hormone in uremic animals and postmenopausal women.
Zella JB; Plum LA; Plowchalk DR; Potochoiba M; Clagett-Dame M; DeLuca HF
Am J Nephrol; 2014; 39(6):476-83. PubMed ID: 24854296
[TBL] [Abstract][Full Text] [Related]
16. Control of parathyroid function in patients with a short history of hemodialysis.
Nishi H; Sato T; Kurihara T; Kurosawa T; Fukagawa M
Ther Apher Dial; 2005 Feb; 9(1):39-43. PubMed ID: 15828904
[TBL] [Abstract][Full Text] [Related]
17. Activation of the calcium receptor by a calcimimetic compound halts the progression of secondary hyperparathyroidism in uremic rats.
Chin JI; Miller SC; Wada M; Nagano N; Nemeth EF; Fox J
J Am Soc Nephrol; 2000 May; 11(5):903-911. PubMed ID: 10770968
[TBL] [Abstract][Full Text] [Related]
18. [Secondary hyperparathyroidism in renal insufficiency. Prevention and therapy].
Malluche HH; Ritz E
MMW Munch Med Wochenschr; 1976 Jan; 118(5):129-30. PubMed ID: 814442
[No Abstract] [Full Text] [Related]
19. Effect of percutaneous calcitriol injection therapy on secondary hyperparathyroidism in uraemic patients.
Shiizaki K; Negi S; Mizobuchi M; Hatamura I; Narukawa N; Sakaguchi T; Kitabata Y; Sumikado S; Akizawa T
Nephrol Dial Transplant; 2003 Jun; 18 Suppl 3():iii42-6. PubMed ID: 12771299
[TBL] [Abstract][Full Text] [Related]
20. Non-suppressible secondary hyperparathyroidism in chronic progressive renal disease.
Slatopolsky E; Rutherford WE; Hoffsten PE; Elkan IO; Butcher HR; Bricker NS
Kidney Int; 1972; 1(1):38-46. PubMed ID: 5075944
[No Abstract] [Full Text] [Related]
[Next] [New Search]
